ArticleScientific reports2020

Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer.

Viswas Raja Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.